{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T16:19:40Z","timestamp":1791821980500,"version":"4.3.4"},"reference-count":30,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,1]]},"abstract":"<jats:sec>\n            <jats:title>Purpose:<\/jats:title>\n            <jats:p>To evaluate whether optical coherence tomography (OCT) can determine polypoidal lesion (PL) perfusion in polypoidal choroidal vasculopathy eyes after 12 months of aflibercept monotherapy. Polypoidal lesion perfusion status, assessed by indocyanine green angiography, is an important anatomical outcome in polypoidal choroidal vasculopathy management.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods:<\/jats:title>\n            <jats:p>Post hoc data from a prospective randomized, open-label, study in eyes with polypoidal choroidal vasculopathy undergoing monotherapy with aflibercept evaluated PL perfusion status based on indocyanine green angiography (gold standard) and OCT features from baseline to 12 months.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>Individual PLs (110 in total) from 48 eyes (48 patients) showed at 12 months; 57\/110 PLs (51.8%) were closed on indocyanine green angiography. At 12 months, eyes with closed PLs were more likely to have the following OCT features: 1) no subretinal fluid (67.1% vs. 32.9%), 2) smaller pigment epithelial detachment height (67.2 [\u00b143.8] vs. 189.2 [\u00b1104.9] <jats:italic toggle=\"yes\">\u03bc<\/jats:italic>m), 3) densely hyperreflective pigment epithelial detachment contents (84.0% vs. 16.0%), 4) an absence of a hyperreflective ring(64.0% vs. 36.0%), and a 5) indistinct overlying retinal pigment epithelial (71.4% vs. 28.6%) (all <jats:italic toggle=\"yes\">P<\/jats:italic> &lt; 0.05). The three highest performing OCT features that differentiated perfused from closed PLs were (1), (3), and (4) (area under the receiver operating characteristic curve 0.85, 0.73, and 0.70, respectively). A combination of these three features achieved an area under the receiver operating characteristic curve of 0.90.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion:<\/jats:title>\n            <jats:p>Polypoidal lesion closure, an important anatomical treatment outcome in polypoidal choroidal vasculopathy typically defined by indocyanine green angiography, can be accurately detected by specific OCT features.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/iae.0000000000003285","type":"journal-article","created":{"date-parts":[[2021,8,19]],"date-time":"2021-08-19T23:58:19Z","timestamp":1629417499000},"page":"114-122","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":7,"title":["OPTICAL COHERENCE TOMOGRAPHY FEATURES OF POLYPOIDAL LESION CLOSURE IN POLYPOIDAL CHOROIDAL VASCULOPATHY TREATED WITH AFLIBERCEPT"],"prefix":"10.1097","volume":"42","author":[{"given":"Anna C. S.","family":"Tan","sequence":"first","affiliation":[{"name":"Singapore Eye Research Institute, Singapore National Eye Centre, Singapore, Singapore;"},{"name":"Duke-NUS Medical School, Singapore, National University of Singapore, Singapore; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janice Marie","family":"Jordan-Yu","sequence":"additional","affiliation":[{"name":"Singapore Eye Research Institute, Singapore National Eye Centre, Singapore, Singapore;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chinmayi Himanshuroy","family":"Vyas","sequence":"additional","affiliation":[{"name":"Singapore Eye Research Institute, Singapore National Eye Centre, Singapore, Singapore;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alfred Tau Liang","family":"Gan","sequence":"additional","affiliation":[{"name":"Singapore Eye Research Institute, Singapore National Eye Centre, Singapore, Singapore;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelvin Yi Chong","family":"Teo","sequence":"additional","affiliation":[{"name":"Singapore Eye Research Institute, Singapore National Eye Centre, Singapore, Singapore;"},{"name":"Duke-NUS Medical School, Singapore, National University of Singapore, Singapore; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"ChoI Mun","family":"Chan","sequence":"additional","affiliation":[{"name":"Singapore Eye Research Institute, Singapore National Eye Centre, Singapore, Singapore;"},{"name":"Duke-NUS Medical School, Singapore, National University of Singapore, Singapore; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ranjana","family":"Mathur","sequence":"additional","affiliation":[{"name":"Singapore Eye Research Institute, Singapore National Eye Centre, Singapore, Singapore;"},{"name":"Duke-NUS Medical School, Singapore, National University of Singapore, Singapore; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tien Yin","family":"Wong","sequence":"additional","affiliation":[{"name":"Singapore Eye Research Institute, Singapore National Eye Centre, Singapore, Singapore;"},{"name":"Duke-NUS Medical School, Singapore, National University of Singapore, Singapore; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Usha","family":"Chakravarthy","sequence":"additional","affiliation":[{"name":"Ophthalmology and Vision Sciences, Queen's University Belfast, Belfast, United Kingdom."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3358-3516","authenticated-orcid":false,"given":"Gemmy Chui Ming","family":"Cheung","sequence":"additional","affiliation":[{"name":"Singapore Eye Research Institute, Singapore National Eye Centre, Singapore, Singapore;"},{"name":"Duke-NUS Medical School, Singapore, National University of Singapore, Singapore; and"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20250607","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1016\/j.ophtha.2017.11.019","article-title":"Polypoidal choroidal vasculopathy: definition, pathogenesis, diagnosis, and management","volume":"125","author":"Cheung","year":"2018","journal-title":"Ophthalmology"},{"key":"R2-20250607","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.preteyeres.2016.04.002","article-title":"Age-related macular degeneration and polypoidal choroidal vasculopathy in Asians","volume":"53","author":"Wong","year":"2016","journal-title":"Prog Retin Eye Res"},{"key":"R3-20250607","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1136\/bjo.2004.049296","article-title":"The origins of polypoidal choroidal vasculopathy","volume":"89","author":"Yuzawa","year":"2005","journal-title":"Br J Ophthalmol"},{"key":"R4-20250607","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.ophtha.2020.08.006","article-title":"Polypoidal choroidal vasculopathy: Consensus nomenclature and non-indocyanine green Angiograph diagnostic criteria from the asia-pacific ocular imaging society PCV workgroup","volume":"128","author":"Cheung","year":"2021","journal-title":"Ophthalmology"},{"key":"R5-20250607","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1001\/archopht.117.11.1503","article-title":"Polypoidal choroidal vasculopathy and neovascularized age-related macular degeneration","volume":"117","author":"Yannuzzi","year":"1999","journal-title":"Arch Ophthalmol"},{"key":"R6-20250607","doi-asserted-by":"crossref","first-page":"2075","DOI":"10.1007\/s00417-015-2933-2","article-title":"The natural history of polypoidal choroidal vasculopathy: a multi-center series of untreated Asian patients","volume":"253","author":"Cheung","year":"2015","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"R7-20250607","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1097\/00006982-199515020-00003","article-title":"Indocyanine green videoangiography of idiopathic polypoidal choroidal vasculopathy","volume":"15","author":"Spaide","year":"1995","journal-title":"Retina"},{"key":"R8-20250607","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/00006982-199010010-00001","article-title":"Idiopathic polypoidal choroidal vasculopathy (IPCV)","volume":"10","author":"Yannuzzi","year":"1990","journal-title":"Retina"},{"key":"R9-20250607","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/j.jcjo.2017.02.014","article-title":"Age-related macular degeneration: is polypoidal choroidal vasculopathy recognized and treated?","volume":"52","author":"Chen","year":"2017","journal-title":"Can J Ophthalmol"},{"key":"R10-20250607","doi-asserted-by":"crossref","first-page":"360","DOI":"10.4103\/0974-9233.120005","article-title":"Long term result of intravitreal bevacizumab in a patient newly transformed to proliferative macular telangiectasia type 2","volume":"20","author":"Ozkaya","year":"2013","journal-title":"Middle East Afr J Ophthalmol"},{"key":"R11-20250607","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.jcjo.2019.10.011","article-title":"Polypoidal choroidal vasculopathy in Canada","volume":"55","author":"Lam","year":"2020","journal-title":"Can J Ophthalmol"},{"key":"R12-20250607","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/S0161-6420(02)01563-4","article-title":"Indocyanine green angiography in chorioretinal diseases: indications and interpretation: an evidence-based update","volume":"110","author":"Stanga","year":"2003","journal-title":"Ophthalmology"},{"key":"R13-20250607","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1001\/jamaophthalmol.2019.0565","article-title":"Sensitivity and specificity of potential diagnostic features detected using fundus photography, optical coherence tomography, and fluorescein angiography for polypoidal choroidal vasculopathy","volume":"137","author":"Chaikitmongkol","year":"2019","journal-title":"JAMA Ophthalmol"},{"key":"R14-20250607","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1016\/j.ajo.2014.08.025","article-title":"Sensitivity and specificity of spectral-domain optical coherence tomography in detecting idiopathic polypoidal choroidal vasculopathy","volume":"158","author":"De Salvo","year":"2014","journal-title":"Am J Ophthalmol"},{"key":"R15-20250607","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1001\/jamaophthalmol.2017.4030","article-title":"Efficacy and safety of ranibizumab with or without verteporfin photodynamic therapy for polypoidal choroidal vasculopathy: a randomized clinical trial","volume":"135","author":"Koh","year":"2017","journal-title":"JAMA Ophthalmol"},{"key":"R16-20250607","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1097\/IAE.0000000000002384","article-title":"Posttreatment polyp regression and risk of massive submacular hemorrhage in eyes with polypoidal choroidal vasculopathy","volume":"40","author":"Cho","year":"2020","journal-title":"Retina"},{"key":"R17-20250607","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1097\/IAE.0000000000000499","article-title":"Three-year results of polypoidal choroidal vasculopathy treated with photodynamic therapy: retrospective study and systematic review","volume":"35","author":"Wong","year":"2015","journal-title":"Retina"},{"key":"R18-20250607","article-title":"Efficacy of a novel personalised aflibercept monotherapy regimen based on polypoidal lesion closure in participants with polypoidal choroidal vasculopathy","author":"Teo","year":"2021","journal-title":"Br J Ophthalmol"},{"key":"R19-20250607","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1136\/bjophthalmol-2014-305674","article-title":"Everest study report 2: imaging and grading protocol, and baseline characteristics of a randomised controlled trial of polypoidal choroidal vasculopathy","volume":"99","author":"Tan","year":"2015","journal-title":"Br J Ophthalmol"},{"key":"R20-20250607","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1002\/bimj.201000035","article-title":"A note on the tests for clustered matched-pair binary data","volume":"52","author":"Yang","year":"2010","journal-title":"Biom J"},{"key":"R21-20250607","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1111\/ceo.13114","article-title":"Understanding aneurysmal type 1 neovascularization (polypoidal choroidal vasculopathy): a lesson in the taxonomy of \u201fexpanded spectra\u201d\u2013a review","volume":"46","author":"Dansingani","year":"2018","journal-title":"Clin Exp Ophthalmol"},{"key":"R22-20250607","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.oret.2018.08.008","article-title":"Clinicopathologic correlation of aneurysmal type 1 neovascularization in age-related macular degeneration","volume":"3","author":"Li","year":"2019","journal-title":"Ophthalmol Retina"},{"key":"R23-20250607","doi-asserted-by":"crossref","first-page":"e0241230","DOI":"10.1371\/journal.pone.0241230","article-title":"Flow signal change in polyps after anti-vascular endothelial growth factor therapy","volume":"15","author":"Chang","year":"2020","journal-title":"PLoS One"},{"key":"R24-20250607","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1097\/IAE.0000000000001391","article-title":"Characterization and differentiation of polypoidal choroidal vasculopathy using swept source optical coherence tomography angiography","volume":"37","author":"Cheung","year":"2017","journal-title":"Retina"},{"key":"R25-20250607","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.ajo.2006.08.025","article-title":"Pigment epithelial detachment in polypoidal choroidal vasculopathy","volume":"143","author":"Tsujikawa","year":"2007","journal-title":"Am J Ophthalmol"},{"key":"R26-20250607","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.ajo.2016.06.014","article-title":"Incidence rate of massive submacular hemorrhage and its risk factors in polypoidal choroidal vasculopathy","volume":"169","author":"Cho","year":"2016","journal-title":"Am J Ophthalmol"},{"key":"R27-20250607","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1097\/IAE.0000000000003098","article-title":"The incidence, characteristics, management, prognosis and classification of breakthrough vitreous hemorrhage secondary to polypoidal choroidal vasculopathy","volume":"41","author":"Zhao","year":"2020","journal-title":"Retina"},{"key":"R28-20250607","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1097\/IAE.0b013e318150d864","article-title":"Retinal pigment epithelial tear in polypoidal choroidal vasculopathy","volume":"27","author":"Tsujikawa","year":"2007","journal-title":"Retina"},{"key":"R29-20250607","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1016\/j.ophtha.2012.04.015","article-title":"Ranibizumab versus bevacizumab to treat neovascular age-related macular degeneration: one-year findings from the IVAN randomized trial","volume":"119","author":"Investigators","year":"2012","journal-title":"Ophthalmology"},{"key":"R30-20250607","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1056\/NEJMoa1102673","article-title":"Ranibizumab and bevacizumab for neovascular age-related macular degeneration","volume":"364","author":"Group","year":"2011","journal-title":"N Engl J Med"}],"container-title":["Retina"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/IAE.0000000000003285","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,7]],"date-time":"2025-06-07T18:06:26Z","timestamp":1749319586000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/IAE.0000000000003285"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1]]},"references-count":30,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.1097\/iae.0000000000003285","relation":{},"ISSN":["0275-004X"],"issn-type":[{"value":"0275-004X","type":"print"}],"subject":[],"published":{"date-parts":[[2022,1]]}}}